Evidence map›Paper›PMID 31475198›Full record

ArticleAnnals of translational medicine2019

High methylation of

Na-Yi Yuan Wu, Xiaoyun Zhang, Tangyuan Chu, Songlin Zhu, Yuping Deng, Yi Zhou, Ying Wang, Xueheng Zhao, Lu Liu, Chao Fang and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Promising predictive molecular biomarkers for cervical cancer (Review).International journal of molecular medicine · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Epigenetics · 2022
    Article
  7. LncRNACancers · 2022
    Article
  8. Article
  9. Article
  10. Methylation ofJournal of Cancer · 2021
    Article
  11. Article
  12. Review
  13. BioMed research international · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Na-Yi Yuan WuHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Xiaoyun ZhangHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Tangyuan ChuDepartment of Obstetrics and Gynecology, Buddhist Tzu Chi General Hospital, Hulien, Taiwan, China.
Songlin ZhuHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Yuping DengHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Yi ZhouHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Ying WangHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Xueheng ZhaoHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Lu LiuHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Chao FangThe Third Xiangya Hospital, Central South University, Changsha 410000, China.
Yang WangHunan Hongya Gene Technology Co., Ltd., Changsha 410000, China.
Yu-Ligh LiouXiangya Medical Laboratory, Central South University, Changsha 410000, China.
Jingting CaiHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Jing WangHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Hunan Cancer Hospital · CNCentral South University · CNBuddhist Tzu Chi General Hospital · TWThird Xiangya Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur previous study demonstrated hypermethylation of the

methodsWe first determined

resultsThe

conclusionsAberrant high methylation of

Indexed as

cervical adenocarcinoma (CAC)chemoradiotherapymethylationZNF582

Identifiers

PMID31475198
PMCPMC6694254
OpenAlexW2952942968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.